Literature DB >> 16978723

Amyloid-beta peptides induce several chemokine mRNA expressions in the primary microglia and Ra2 cell line via the PI3K/Akt and/or ERK pathway.

Sachiko Ito1, Makoto Sawada, Masataka Haneda, Yoshiyuki Ishida, Ken-ichi Isobe.   

Abstract

Alzheimer's disease (AD) is characterized by the presence of senile plaques composed primarily of amyloid-beta peptide (Abeta) in the brain. Microglia have been reported to surround these Abeta plaques, which have opposite roles, provoking a microglia-mediated inflammatory response that contributes to neuronal cell loss or the removal of Abeta and damaged neurons. To perform these tasks microglia migrate to the sites of Abeta secretion. We herein analyzed the process of chemokine expression induced by Abeta stimulation in primary murine microglia and Ra2 microglial cell line. We found that Abeta1-42 induced the expressions of CCL7, CCL2, CCL3, CCL4 and CXCL2 in the microglia. The signal transduction pathway for the expression of CCL2 and CCL7 mRNA induced by Abeta1-42 was found to depend on phosphatidylinositol 3-kinase (PI3K)/Akt and extracellular signal-regulated kinase (ERK), whereas the pathway for CCL4 depended only on PI3K/Akt. These inflammatory chemokine expressions by Abeta stimulation emphasize the contribution of neuroinflammatory mechanisms to the pathogenesis of AD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16978723     DOI: 10.1016/j.neures.2006.07.009

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  19 in total

1.  Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments.

Authors:  Antonella Caccamo; Smita Majumder; Arlan Richardson; Randy Strong; Salvatore Oddo
Journal:  J Biol Chem       Date:  2010-02-23       Impact factor: 5.157

Review 2.  Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic intervention.

Authors:  Malú G Tansey; Melissa K McCoy; Tamy C Frank-Cannon
Journal:  Exp Neurol       Date:  2007-07-17       Impact factor: 5.330

3.  Chemokines, macrophage inflammatory protein-2 and stromal cell-derived factor-1α, suppress amyloid β-induced neurotoxicity.

Authors:  Dayanidhi Raman; Snjezana-Zaja Milatovic; Dejan Milatovic; Ryan Splittgerber; Guo-Huang Fan; Ann Richmond
Journal:  Toxicol Appl Pharmacol       Date:  2011-06-17       Impact factor: 4.219

4.  Age-related brain expression and regulation of the chemokine CCL4/MIP-1β in APP/PS1 double-transgenic mice.

Authors:  Min Zhu; Joanne S Allard; Yongqing Zhang; Evelyn Perez; Edward L Spangler; Kevin G Becker; Peter R Rapp
Journal:  J Neuropathol Exp Neurol       Date:  2014-04       Impact factor: 3.685

5.  Naturally secreted amyloid-beta increases mammalian target of rapamycin (mTOR) activity via a PRAS40-mediated mechanism.

Authors:  Antonella Caccamo; Monica A Maldonado; Smita Majumder; David X Medina; Walter Holbein; Andrea Magrí; Salvatore Oddo
Journal:  J Biol Chem       Date:  2011-01-25       Impact factor: 5.157

Review 6.  Targeting the mTOR signaling network for Alzheimer's disease therapy.

Authors:  Chong Wang; Jin-Tai Yu; Dan Miao; Zhong-Chen Wu; Meng-Shan Tan; Lan Tan
Journal:  Mol Neurobiol       Date:  2013-07-14       Impact factor: 5.590

7.  Genome-wide network-based pathway analysis of CSF t-tau/Aβ1-42 ratio in the ADNI cohort.

Authors:  Wang Cong; Xianglian Meng; Jin Li; Qiushi Zhang; Feng Chen; Wenjie Liu; Ying Wang; Sipu Cheng; Xiaohui Yao; Jingwen Yan; Sungeun Kim; Andrew J Saykin; Hong Liang; Li Shen
Journal:  BMC Genomics       Date:  2017-05-30       Impact factor: 3.969

8.  Inflammatory cytokines stimulate the chemokines CCL2/MCP-1 and CCL7/MCP-3 through NFkB and MAPK dependent pathways in rat astrocytes [corrected].

Authors:  Wendy L Thompson; Linda J Van Eldik
Journal:  Brain Res       Date:  2009-07-03       Impact factor: 3.252

Review 9.  Neuroinflammation in Parkinson's disease.

Authors:  Jae-Kyung Lee; Thi Tran; Malú G Tansey
Journal:  J Neuroimmune Pharmacol       Date:  2009-10-10       Impact factor: 4.147

10.  Does neuroinflammation fan the flame in neurodegenerative diseases?

Authors:  Tamy C Frank-Cannon; Laura T Alto; Fiona E McAlpine; Malú G Tansey
Journal:  Mol Neurodegener       Date:  2009-11-16       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.